Creative Biolabs: Looking Forward to Meeting Again at the Next BIO!

New York – June 21, 2022 /MarketersMEDIA/ —

It has been over two years since in-person conferences were suspended due to the global pandemic, COVID-19. In 2022, the rejuvenation of face-to-face affairs provided great opportunities for companies like Creative Biolabs to present their latest advancements and seek partnership opportunities, which exhibited at the 2022 BIO International Convention from June 13 to 16.

“BIO 2022 has been a grand affair ever since the COVID-19 epidemic,” said a delegate of Creative Biolabs, “enabling us to chat with scientists in areas related to drug discovery and disease studies.”

“During our exhibition, we prepared fancy gifts for those who dropped by our booth and chatted, as a way of expressing our gratitude. We also held in-booth activities such as raffles and food catering, hoping to attract more attendees to visit our booth and take the chance to learn more about Creative Biolabs.”

A short bio of Creative Biolabs’ specialties:

* Antibody sequencing service

Taking advantage of the proprietary Database Assisted Shotgun Sequencing (DASS) technology, Creative Biolabs can precisely differentiate leucine from isoleucine, achieving 100% coverage of the variable region, variable plus leader region, as well as full-length heavy- and light-chain antibodies for all species, isotypes, and allotypes.

* Membrane protein antibody service

An exclusive platform—Magic™ supports the preparation of membrane protein as an immunogen, covering cell-based or cell-free membrane protein expression and anti-membrane protein antibody production using lipoparticles, proteoliposomes, nanodiscs, and polymers.

* Single domain antibody service

Specialists take advantage of the ample animal resources and the classic phage display technology for single-domain antibody preparation and high-throughput screening that supports the isolation of high-potency antibody candidates.

Creative Biolabs has several exhibition affairs scheduled for 2022, two of which are happening in September, i.e., World ADC San Diego and the 13th World Multispecifics Summit.

“We really cherish such in-person networking events,” added the delegate, “which are the most efficient and intuitive way for us to learn about clients’ projects and let them know what we can do and how we are distinctive from peers.”

Learn more about Creative Biolabs’ event schedule at https://events.creative-biolabs.com/.

About

Creative Biolabs is a CRO working specifically in immunology studies and new drug discovery. Since the outbreak of COVID-19, Creative Biolabs has fully contributed to the research on SARS-CoV-2 and its variants, as well as the R&D of COVID-19 vaccines. In 2022, a team of delegates, on behalf of Creative Biolabs, will present their competence in drug discovery at global conferences in the form of on-site exhibitions and face-to-face meetings.

Contact Info:
Name: Candy Swift
Email: Send Email
Organization: Creative Biolabs
Website: https://www.creative-biolabs.com/

Release ID: 89077090

If you detect any issues, problems, or errors in this press release content, kindly contact error@releasecontact.com to notify us. We will respond and rectify the situation in the next 8 hours.